Xenocor
Salt Lake City
About Xenocor
Xenocor offers a suite of leading edge, fog-free, single-use endoscopes for minimally invasive surgical procedures. This technology emerged from the Center for Medical Innovation at the University of Utah. The current product offerings are FDA cleared, CE Marked and patent protected.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $10.0M
- Funding stage: Early Stage Venture
- Last round: Series A (Apr 2023)
- Website: xenocor.com
- Phone: 435-680-9782
Industries & Categories
Medical Device
Social Profiles
Canonical: https://fsome.com/organization/xenocor-39816 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.